PROM1 and cancer: After CA treatment, the mRNA expression of the cancer stem cell-related genes Nestin, OCT4, and CD133 in GBM8401-CSC was significantly reduced (Figure 2D), further supporting the ability of CA to inhibit stem cell characteristics.